Sammenlignet med simvastatin alene sænkede supplementet med gemfibrozil yderligere plasmakoncentrationerne af totalt kolesterol med 14, 9%, VLDL- kolesterol med 23, 5% og triglycerider med 17, 1%, selv om dette ikke var statistisk signifikant.
Compared to simvastatin alone the addition of gemfibrozil further lowered plasma concentrations of total cholesterol by 14.9%, VLDL cholesterol by 23.5%, and triglycerides by 17.1%, although this was not statistically significant.